- BUZZ - Nvidia shares rise after announcing an increase of $150 billion in stock buybacks
- Saudi Arabia resumes oil exports after repairing East-West oil pipeline
- Pioneer Altcoin ETH Trades Under $2,700 Missing a Weekly Close Above $2,800, Can $3,400 Still Be Reclaimed?
- --BofA Securities Adjusts Vaxcyte Price Target to $130 From $133, Maintains Buy Rating
- BluMetric Environmental Extends Mine Water Remediation Contract for 2027 Season
- GRAFTECH INTERNATIONAL LTD <EAF.N>: BMO RAISES TARGET PRICE TO $9 FROM $7.5
- STEEL DYNAMICS INC <STLD.O>: BMO CUTS TARGET PRICE TO $290 FROM $296
- TransDigm Completes Acquisition Of Prince & Izant >TDG
- Vestis Names Russell Tiejema CFO; Maintains 2026 Outlook
- Monness Crespi & Hardt Adjusts Meta Platforms Price Target to $830 From $730
- ecoWise names Low Yong Zhen as chief operating officer
- Hana 31 SPAC shares on KOSDAQ are halted on delisting trigger notification
- Slate Grocery: All-cash Transaction of $13 Per Unit, Representing a Total Enterprise Value of $2.3B >SGR.U.T
- Slate Grocery REIT agrees to US$13 per-unit buyout by Brixmor-Everview venture
- XENCOR, INC. <XNCR.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $29 FROM $27
- --B. Riley Cuts Price Target on Scholastic to $35 From $42, Keeps Neutral Rating
- Arvinas Doses First Patient in Phase 1/2 Trial of ARV-6723 for Solid Tumors
- Slate Grocery REIT Enters Into Definitive Agreement To Be Acquired By Brixmor And Everview Partners In A US$2.3 Billion Transaction For US$13.00 Per Unit In Cash >SGR.UN.T
- SAFEHOLD INC <SAFE.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $13 FROM $17
- Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis
- Eldorado Gold Completes Energization of Skouries Mine in Greece
- UK government bond yields rise, attracting capital attention
- BUZZ-MediciNova shares fall as its drug for fatty liver fails to achieve statistical significance in lowering blood lipids
- Saudi Arabia's East-West Pipeline Resumes Oil Exports
- Market Chatter: East-West Pipeline in Saudi Arabia has Restarted Oil Exports
- Palatin Doesn't Expect Existing Cash and Cash Equivalents to Be Sufficient to Fund Ops for at Least 12 Mos >PTN
- Palatin: Substantial Doubt Exists About Ability to Continue as a Going Concern >PTN
- Gerresheimer schedules Q1 quarterly financial report release
- IQVIA HOLDINGS INC. <IQV.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $329 FROM $300
- Fasadgruppen explores SEK 1.25 billion senior secured bond issue
- Palatin: Additional Funding Will Be Required to Continue Advancing Development Programs and Fund Ops >PTN
- Palatin Cash and Cash Equivalents Were $7.5 M as of June 30 >PTN
- US Dollar Mixed Early Monday, Focus on September Employment Report
- META : MONNESS CRESPI HARDT RAISES TARGET PRICE TO $830 FROM $730
- As Whales Accumulate Ethereum, an Analyst Reveals the Only Obstacle Standing in the Way of the ETH Rally!
- Thunder Gold intersects 232.5 m at 0.450 g/t gold at Tower Mountain project in Ontario
- Immuneering presents AACR data linking atebimetinib plus mGnP to longer survival in pancreatic cancer study
- CervoMed plans neflamapimod 100 mg twice-daily regimen for future clinical trials
- Amber International schedules annual general meeting
- Valley National Bancorp to buy Bluevine for USD 340 million
- Valley National Bancorp Sees Acquisition About 8% Accretive to 2028 EPS >VLY
- Palatin Technologies 4Q Loss/Shr $1.11 >PTN
- CLEARWAY ENERGY INC <CWEN.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $40 FROM $43
- 10X GENOMICS, INC. <TXG.O>: ARGUS RESEARCH INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $110
- Egeria-backed Employment Group agrees to merge with DIT Group
- SCYNEXIS wins BARDA contract worth up to $214 million for SCY-247 development
- Rio2 suspends Fenix Gold mining operations after severe winter storms disrupt ramp-up
- Diamond Estates Wines & Spirits holds annual shareholder meeting
- Palatin net loss narrows to $8.38 million in FY26; revenue turns to $13.19 million
- As security concerns heat up, NVIDIA (NVDA.US) introduces engineering responses! Dual-layer AI security platform directly addresses agent permissions and abnormal behaviors.
- Ramaco wins USD 30 million jury verdict in insurance coverage suit against Chubb
- Ares Strategic Mining identifies 49 fluorspar targets at Utah Spor Mountain project via satellite survey
- Google will invest at least 15.2 billions USD in Finland over the next two years.
- Deutsche Bank cuts price targets for Pepsi, Nike, and Costco
- Base Carbon says Verra tags 639,609 Rwanda cookstove credits as CORSIA-eligible
- Snowflake plans to privately issue $3.5 billion in convertible senior notes.
- King Copper Discovery appoints David Burrows to technical advisory team
- Brixmor Property, Everview Partners to Acquire Slate Grocery REIT in $2.34 Billion Deal
- Valley National Bancorp to Acquire Bluevine for About $340 Million >VLY
- Valley National Bancorp: Bluevine Consideration to Consist of About 75% Cash, 25% Stock >VLY
- A2Gold starts 3,700-meter RC drill program at Eastside gold-silver project in Nevada
- Soluna expands Bitdeer co-mining deal to 35 MW at Project Kati 1
- Menē launches share buyback for up to 7,544,143 shares
- Agnico Eagle updates financial calendar with third-quarter results release, conference call
- Soluna expands Bitdeer co-mining deal to 35 MW at Texas Project Kati 1
- Canopy Growth names Sebastian Blöte Germany country manager
- Valley National Bancorp To Acquire Bluevine Inc., Accelerating Its Digital Small Business Growth Strategy And Meaningfully Enhancing Its Core Funding Capabilities >VLY
- Valley National Bancorp: Bluevine is Digital Banking Platform for Small Businesses >VLY
- ADF GROUP INC <DRX.TO>: VENTUM FINANCIAL INITIATES COVERAGE WITH BUY RATING; PRICE TARGET C$20.5
- CONSTELLIUM SE <CSTM.N>: BMO CUTS TARGET PRICE TO $36 FROM $40
- Bitcoin falls below $82,700 as exchange liquidity piles up, $70 million in longs liquidated
- Acurast’s AI deployment now runs on 280,000 smartphones worldwide
- Evercore says the SpaceX Colossus project offers significant EBITDA upside potential.
- Vigo Photonics adjusted EBITDA jumps to PLN 8 million in Q2 2026; revenue rises 71% to PLN 34.6 million y/y
- Merck Signs Exclusive License Agreement for SciBrunch Therapeutics SPR2015 Inhibitor
- Canadian Dollar Vulnerable to Near-Term Weakness, With Recovery Expected Next Year, CIBC Says
- COMMERCIAL METALS CO <CMC.N>: BMO CUTS TARGET PRICE TO $75 FROM $80
- Top Premarket Gainers
- CAPSTONE COPPER CORP <CS.TO>: BMO RAISES TARGET PRICE TO C$18 FROM C$17
- --William Blair Downgrades Acuity to Market Perform From Outperform
- ERO COPPER CORP. <ERO.TO>: BMO RAISES TARGET PRICE TO C$60 FROM C$52
- FIRST QUANTUM MINERALS LTD. <FM.TO>: BMO RAISES TARGET PRICE TO C$60 FROM C$53
- Nvidia is expected to implement a buyback plan by fiscal year 2028.
- Nvidia increases its buyback authorization by $150 billion, bringing the remaining total to $235 billion.
- Nvidia increases stock buyback authorization by $150 billion
- --East-West Pipeline in Saudi Arabia Resumes Oil Exports, Bloomberg Reports
- HUDBAY MINERALS INC. <HBM.TO>: BMO RAISES TARGET PRICE TO C$50 FROM C$44
- Osisko Metals Posts New Drill Results From Gaspe Copper Project
- IVANHOE ELECTRIC INC. <IE.A>: BMO RAISES TARGET PRICE TO $24 FROM $21
- IVANHOE MINES LTD. <IVN.TO>: BMO RAISES TARGET PRICE TO C$19 FROM C$16
- Nvidia Increases Share Repurchase Authorization by $150 Billion to $235 Billion Through Fiscal 2028
- WARRIOR MET COAL INC <HCC.N>: BMO RAISES TARGET PRICE TO $100 FROM $95
- LUNDIN MINING CORPORATION <LUN.TO>: BMO RAISES TARGET PRICE TO C$49 FROM C$45
- Goldcana Resources Raises CA$2 Million Via Non-Brokered Private Placement of Units
- Crude Oil Prices Rise Following US Rejections of Iran Talks Proposal
- OSISKO METALS INC (ONTARIO) <OM.TO>: BMO RAISES TARGET PRICE TO C$3.5 FROM C$2.5
- Aurora UK Alpha fund manager Gary Channon to present half-year results Sept. 29 webcast
- --Snowflake Plans Private Placement of $3.5 Billion of Convertible Notes
- Oil, Bond, AI Outlooks Damp Wall Street Pre-Bell; Asia Off, Europe Up
- BRIEF-Merck Enters Exclusive Global License Deal With Scibrunch Therapeutics For SPR2015
